The General Data Protection Regulation (GDPR) has clear guidelines with regards to data protection. However that doesn’t result in a homogeneous implementation throughout each sector. There’s no need to say that a pharmaceutical company, dealing with loads of data from numerous individuals, obtained via multiple platforms, has lots of obstacles to tackle when it comes to GDPR.
On December 5th, we organized a tailor-made GDPR tutorial in cooperation with UCB.
Under the guidance of Nathan Lea (i~HD Information Governance & GDPR taskforce) and supported by field experts Mariana Rissetto (Department of Innovation and Digitalisation in Law at the University of Vienna), Petra Wilson (Health Connect Partners), Ruben Roex (research group Law & Technology at the University of Ghent) and Brendan Barnes (EFPIA) our i~HD taskforce focused on topics as:
To wrap up the day we had a very interactive panel discussion. We can conclude that accurate accountability and a customized approach are the main keys to tackle GDPR.
We look back on a successful tutorial with very interesting discussions and constructive dialogues. A special thanks to the UCB team including the RWE practice for the warm welcome and pleasant cooperation.
The mission of The European Institute for Innovation through Health Data (i~HD) is to enable, coordinate, and accelerate the efficient development and deployment of interoperable and seamless eHealth solutions and research strategies, towards achieving best practices and sustainable integrated person-centred health care, to optimise health and wellness in Europe, and beyond. It aims to guide and catalyse the best, most efficient and trustworthy uses of health data and interoperability, for optimising health and knowledge discovery.
i~HD has been established to tackle areas of challenge in the successful scaling up of innovations that critically rely on high quality and interoperable health data. It specifically addresses obstacles and opportunities to using health data by collating, developing and promoting best practices in information governance and in semantic interoperability. It is helping to sustain and propagate the results of health information and communication technology (ICT) research that enable better use of health data, assessing and optimising their novel value wherever possible.
i~HD has been formed after wide consultation and engagement of many stakeholders to develop methods, solutions and services that can help to maximise the value obtained by all stakeholders from health data. It supports innovations in health maintenance, health care delivery and in knowledge discovery, while ensuring compliance with all legal prerequisites, especially regarding the insurance of patient’s privacy protection. It unites multiple stakeholder groups to ensure that future solutions serve their collective needs and can be readily adopted affordably and at scale.